Snyder AB - Search Results

1

Transfusion service knowledge and immunohaematological practices related to sickle cell disease and thalassemia.

Fasano RM, Branscomb J, Lane PA, Josephson CD, Snyder AB, Eckman JR. Fasano RM, et al. Among authors: snyder ab. Transfus Med. 2019 Jun;29(3):185-192. doi: 10.1111/tme.12580. Epub 2019 Feb 10. Transfus Med. 2019. PMID: 30740798 Free PMC article. Clinical Trial.

2

Defining Sickle Cell Disease Mortality Using a Population-Based Surveillance System, 2004 through 2008.

Paulukonis ST, Eckman JR, Snyder AB, Hagar W, Feuchtbaum LB, Zhou M, Grant AM, Hulihan MM. Paulukonis ST, et al. Among authors: snyder ab. Public Health Rep. 2016 Mar-Apr;131(2):367-75. doi: 10.1177/003335491613100221. Public Health Rep. 2016. PMID: 26957672 Free PMC article.

3

Determining Adherence to Quality Indicators in Sickle Cell Anemia Using Multiple Data Sources.

Neunert CE, Gibson RW, Lane PA, Verma-Bhatnagar P, Barry V, Zhou M, Snyder A. Neunert CE, et al. Am J Prev Med. 2016 Jul;51(1 Suppl 1):S24-30. doi: 10.1016/j.amepre.2016.02.011. Am J Prev Med. 2016. PMID: 27320461 Free PMC article.

4

The accuracy of hospital ICD-9-CM codes for determining Sickle Cell Disease genotype.

Snyder AB, Lane PA, Zhou M, Paulukonis ST, Hulihan MM. Snyder AB, et al. J Rare Dis Res Treat. 2017;2(4):39-45. Epub 2017 Jul 28. J Rare Dis Res Treat. 2017. PMID: 29202133 Free PMC article.

5

Improving an Administrative Case Definition for Longitudinal Surveillance of Sickle Cell Disease.

Snyder AB, Zhou M, Theodore R, Quarmyne MO, Eckman J, Lane PA. Snyder AB, et al. Public Health Rep. 2019 May/Jun;134(3):274-281. doi: 10.1177/0033354919839072. Epub 2019 Apr 10. Public Health Rep. 2019. PMID: 30970223 Free PMC article.

6

Characterizing complication risk from multisite, intermittent transfusions for the treatment of sickle cell disease.

Tang A, Branscomb J, Zhou M, Snyder A, Eckman J. Tang A, et al. Pediatr Blood Cancer. 2019 Oct;66(10):e27921. doi: 10.1002/pbc.27921. Epub 2019 Jul 18. Pediatr Blood Cancer. 2019. PMID: 31318157

7

Hematologist encounters among Medicaid patients who have sickle cell disease.

Horiuchi SS, Zhou M, Snyder A, Paulukonis ST. Horiuchi SS, et al. Blood Adv. 2022 Sep 13;6(17):5128-5131. doi: 10.1182/bloodadvances.2022007622. Blood Adv. 2022. PMID: 35819456 Free PMC article. No abstract available.

8

Improving Outcomes for Patients With Sickle Cell Disease in the United States: Making the Case for More Resources, Surveillance, and Longitudinal Data.

Kanter J, Meier ER, Hankins JS, Paulukonis ST, Snyder AB. Kanter J, et al. Among authors: snyder ab. JAMA Health Forum. 2021 Oct 1;2(10):e213467. doi: 10.1001/jamahealthforum.2021.3467. JAMA Health Forum. 2021. PMID: 36218900 Free article. Review.

9

Trends in blood transfusion, hydroxyurea use, and iron overload among children with sickle cell disease enrolled in Medicaid, 2004-2019.

Tang AY, Zhou M, Maillis AN, Lai KW, Lane PA, Snyder AB. Tang AY, et al. Among authors: snyder ab. Pediatr Blood Cancer. 2023 Mar;70(3):e30152. doi: 10.1002/pbc.30152. Epub 2022 Dec 29. Pediatr Blood Cancer. 2023. PMID: 36579749

10

Immunization adherence among children with sickle cell disease and sickle cell trait: Results of a population-based study.

Shi JS, Sutaria A, Lakshmanan S, Attell B, Zhou M, Tang A, Eckman J, Snyder A. Shi JS, et al. Pediatr Blood Cancer. 2024 Jul;71(7):e31042. doi: 10.1002/pbc.31042. Epub 2024 May 3. Pediatr Blood Cancer. 2024. PMID: 38702922

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters